MT Group Blog

Filter

Broadened biospecimen collection capabilities for 2023

January 12, 2023
Before the end-of-year cheer is exchanged for 2023’s hecticness, MT Group would like to take…

Optimizing year-end budgets with high value FFPE

September 28, 2022
It is coming up on the end of the year and many MT Group customers…

IO-experienced biospecimens for translational development

July 26, 2022
Are you active in immuno-oncology? If so, you’re not alone - there are now hundreds of…

Comprehensively annotated biospecimens from NASH patients

June 16, 2022
Are you active in non-alcoholic-steatohepatitis (NASH) research?  Maybe you're investigating blood biomarkers for a clinical…

Customized COVID Biospecimen Collections To Power Your R&D

January 11, 2022
Are you working in COVID R&D?  Might you have need for a custom biospecimen collection? …

Customized FFPE tissue collection capabilities

December 7, 2021
Do you work with FFPE tissue? MT Group sites have collected thousands of FFPEs for…

Autoimmune disease biospecimens

November 9, 2021
Are you studying autoimmune diseases? Perhaps you’re investigating pathologies affecting the digestive system, skin and…

Fresh tumor tissue for translational research

October 7, 2021
Do you work with fresh tumor tissue? MT Group does - we began collecting these…

Longitudinal biospecimen & data collections

August 30, 2021
The MT Group has longitudinally collected biospecimens for pharmaceutical R&D from thousands of subjects, regularly…